5815 related articles for article (PubMed ID: 3719568)
1. Tumor metastasis-associated heparanase (heparan sulfate endoglycosidase) activity in human melanoma cells.
Nakajima M; Irimura T; Nicolson GL
Cancer Lett; 1986 Jun; 31(3):277-83. PubMed ID: 3719568
[TBL] [Abstract][Full Text] [Related]
2. Specificity and action pattern of heparanase Bp, a β-glucuronidase from Burkholderia pseudomallei.
Yu Y; Williams A; Zhang X; Fu L; Xia K; Xu Y; Zhang F; Liu J; Koffas M; Linhardt RJ
Glycobiology; 2019 Jul; 29(8):572-581. PubMed ID: 31143933
[TBL] [Abstract][Full Text] [Related]
3. Significance of host heparanase in promoting tumor growth and metastasis.
Zhang GL; Gutter-Kapon L; Ilan N; Batool T; Singh K; Digre A; Luo Z; Sandler S; Shaked Y; Sanderson RD; Wang XM; Li JP; Vlodavsky I
Matrix Biol; 2020 Nov; 93():25-42. PubMed ID: 32534153
[TBL] [Abstract][Full Text] [Related]
4. PCNA expression and nucleolar organizer regions in malignant melanoma and nevus cell nevus.
Kanoko M; Ueda M; Ichihashi M
Kobe J Med Sci; 1994 Aug; 40(3-4):107-23. PubMed ID: 7739200
[TBL] [Abstract][Full Text] [Related]
5. Symptomatic metastatic malignant melanoma to the spine.
Donaldson WF; Peppelman WC; Yaw KM
J Spinal Disord; 1993 Aug; 6(4):360-3. PubMed ID: 7693073
[TBL] [Abstract][Full Text] [Related]
6. Propagation of a poorly differentiated human pulmonary adenocarcinoma in nude athymic rats.
Korsgaard R; Lindén CJ; Willén R; Willén H; Svensson G; Simonsson BG
Int J Cancer; 1983 Dec; 32(6):793-9. PubMed ID: 6654530
[TBL] [Abstract][Full Text] [Related]
7. Melanoma regression induced by "chalone": a new tumour inhibiting principle acting in vivo.
Mohr U; Althoff J; Kinzel V; Süss R; Volm M
Nature; 1968 Oct; 220(5163):138-9. PubMed ID: 5684822
[No Abstract] [Full Text] [Related]
8. Synthetic laminin-like peptides and pseudopeptides as potential antimetastatic agents.
Zhao M; Kleinman HK; Mokotoff M
J Med Chem; 1994 Sep; 37(20):3383-8. PubMed ID: 7932566
[TBL] [Abstract][Full Text] [Related]
9. Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia TNF alpha and melphalan: Swedish experience.
Hafström L; Naredi P
Recent Results Cancer Res; 1998; 147():120-6. PubMed ID: 9670274
[TBL] [Abstract][Full Text] [Related]
10. Synthetic dipeptide, N-stearoyl-D-Ser-L-Pro-OEt, induces release of tissue-type plasminogen activator in cultured cells and in experimental animals.
Okayama T; Nakano M; Odake S; Hagiwara M; Morikawa T; Ueshima S; Okada K; Fukao H; Matsuo O
Chem Pharm Bull (Tokyo); 1994 Sep; 42(9):1854-8. PubMed ID: 7954938
[TBL] [Abstract][Full Text] [Related]
11. A special surface coil for high-resolution ocular MRI.
Hosten N; Lemke AJ
Front Radiat Ther Oncol; 1997; 30():20-5. PubMed ID: 9205881
[No Abstract] [Full Text] [Related]
12. Volume-activated Cl- currents in different mammalian non-excitable cell types.
Nilius B; Sehrer J; Viana F; De Greef C; Raeymaekers L; Eggermont J; Droogmans G
Pflugers Arch; 1994 Oct; 428(3-4):364-71. PubMed ID: 7816559
[TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus in cancer patients treated with combination interleukin 2 and alpha-interferon.
Whitehead RP; Hauschild A; Christophers E; Figlin R
Cancer Biother; 1995; 10(1):45-51. PubMed ID: 7780486
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of phenyl- and benzoylpyrroles.
Laatsch H; Renneberg B; Hanefeld U; Kellner M; Pudleiner H; Hamprecht G; Kraemer HP; Anke H
Chem Pharm Bull (Tokyo); 1995 Apr; 43(4):537-46. PubMed ID: 7600609
[TBL] [Abstract][Full Text] [Related]
15. Malignant hypomelanotic melanoma of mules. A histologic, immunohistochemical and ultrastructural study of a case with unknown primary site and widespread metastases.
Giuffré G; Muscarella A; Muscarà M; Todaro P; Tuccari G
Pathologica; 1995 Feb; 87(1):100-4. PubMed ID: 7567160
[TBL] [Abstract][Full Text] [Related]
16. [Role of asialo GM 1 positive cells in the control of metastatic spread of tumor cells in mice].
Shibuya M; Saijo N; Ozaki A; Beppu Y; Shimizu E; Takizawa T; Hoshi A
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1781-6. PubMed ID: 6882003
[TBL] [Abstract][Full Text] [Related]
17. The stability of tissue plasminogen activator (t-PA).
Gaffney PJ; Templeman J; Curtis AD; Campbell PJ
Thromb Haemost; 1983 Oct; 50(3):650-1. PubMed ID: 6685926
[TBL] [Abstract][Full Text] [Related]
18. Differential susceptibility and cytopathic alterations induced by PTT. 119, a new cancericidal compound, p-fluoro-Phe-L-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl.
Yagi MJ; Bekesi JG
Biomed Pharmacother; 1983; 37(7):329-38. PubMed ID: 6667339
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and histochemical characteristics of target antigen detected by monoclonal antibody HBCA-12 against a membrane component of human mammary carcinoma cell line.
Kovarík J; Chorváth B; Duraj J; Bártek J; Rejthar A; Lauerová L; Babusíková O
Neoplasma; 1984; 31(6):625-9. PubMed ID: 6521796
[TBL] [Abstract][Full Text] [Related]
20. Sarcoma growth factor and other transforming peptides produced by human cells: interactions with membrane receptors.
Todaro GJ; De Larco JE; Fryling CM
Fed Proc; 1982 Nov; 41(13):2996-3003. PubMed ID: 6292003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
